![Context Therapeutics Inc](/common/images/company/N_CNTX.png)
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and ... Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. Show more
CT-95 is a potentially first-in-class mesothelin x CD3 bispecific antibody Acquisition expands Context pipeline with second clinical-stage T cell engager for solid tumors PHILADELPHIA, July 10...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.37 | 17.3708920188 | 2.13 | 2.54 | 2.06 | 80946 | 2.2792177 | CS |
4 | 0.52 | 26.2626262626 | 1.98 | 2.54 | 1.7301 | 96328 | 2.05815611 | CS |
12 | 0.8 | 47.0588235294 | 1.7 | 2.54 | 1.352 | 345661 | 2.01192128 | CS |
26 | 1.5798 | 171.68006955 | 0.9202 | 2.54 | 0.9202 | 399065 | 1.81695608 | CS |
52 | 1.44 | 135.849056604 | 1.06 | 2.54 | 0.77 | 217660 | 1.75169327 | CS |
156 | -1.94 | -43.6936936937 | 4.44 | 10.87 | 0.47 | 816768 | 3.77393843 | CS |
260 | -1.94 | -43.6936936937 | 4.44 | 10.87 | 0.47 | 816768 | 3.77393843 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.